6550-- Ventena Contract Request
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), Network Contracting Office 17, has issued a Special Notice announcing its intent to award a sole-source, firm-fixed-price Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Roche Diagnostics Corporation. This procurement is for essential reagents and consumable supplies required for the Ventana BenchMark Ultra system. This notice is for informational purposes and is not a request for proposals.
Purpose & Scope
The VA requires a continuous supply of specific reagents, staining kits, antibodies, and ancillaries for its Ventana BenchMark Ultra system. The government states that these 40 listed items are exclusively compatible with their existing equipment, making Roche Diagnostics Corporation the only responsible source. The contract will operate as a standing order, with supplies procured on an as-needed basis over a five-year ordering period.
Contract Details
- Type: Firm-Fixed-Price IDIQ
- Duration: Five-year ordering period
- Set-Aside: Sole Source (Other than Full and Open Competition, justified under 41 U.S.C. 3304(a)(1) and FAR 6.302-1)
- Pricing: Open market pricing agreement
- Product Service Code: 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits And Sets)
Submission & Evaluation
This notice is not a solicitation for quotations or proposals. However, responsible sources are invited to submit a capability statement, proposal, or quotation. The agency will review these submissions to determine if a comparable and more advantageous source is available. If no affirmative written response is received within 5 days of the notice's publication (by the response date), the contract will be awarded to Roche Diagnostics Corporation without further notice.
Key Dates & Contact
- Response Due: February 9, 2026, by 11:00 AM ET (10:00 AM CT)
- Published Date: February 3, 2026
- Contracting Office: VA, Network Contracting Office 17 (36C257)
- Primary Contact: Susan Flores, Contract Specialist, Susan.flores2@va.gov, (210) 694-6227